Summa Bio Solutions, Inc.
SUMMA Bio-Solutions is a biotechnology company focused on developing cellular medical solutions for degenerative medical conditions affecting both humans and animals. The company leverages advanced research and technology to provide innovative therapies aimed at improving health outcomes through bioscience.
Industries
N/A
Nr. of Employees
small (1-50)
Summa Bio Solutions, Inc.
500 8th Avenue, Fort Worth, Texas 76104, United States
Products
Mesenchymal cell-derived conditioned medium (product candidate)
A cell-free conditioned medium containing secreted immuno-regulatory proteins and exosomes produced from an immortalized mesenchymal stem cell line, processed to remove cellular material and aseptically filled; intended as a therapeutic candidate to modulate excessive immune responses.
Peripheral blood-derived pluripotent cell banking and derived cell lines
Services and products related to recovery, cryopreservation, and distribution of peripheral blood-derived pluripotent cells, and in vitro differentiated cell lines and organoids derived from those cells.
Mesenchymal cell-derived conditioned medium (product candidate)
A cell-free conditioned medium containing secreted immuno-regulatory proteins and exosomes produced from an immortalized mesenchymal stem cell line, processed to remove cellular material and aseptically filled; intended as a therapeutic candidate to modulate excessive immune responses.
Peripheral blood-derived pluripotent cell banking and derived cell lines
Services and products related to recovery, cryopreservation, and distribution of peripheral blood-derived pluripotent cells, and in vitro differentiated cell lines and organoids derived from those cells.
Services
Processing of peripheral blood submissions to recover naturally occurring pluripotent stem cells for immediate therapeutic use or banking.
Cryopreservation and long-term storage services for recovered pluripotent cells and derived cell lines, with SOP-driven operations in FDA-licensed facilities.
In vitro generation of organoid tissue buds from peripheral blood-derived pluripotent cells for laboratory testing, drug discovery, and potential tissue-engineering applications.
Manufacture and formulation of a cell-free mesenchymal stem cell-conditioned medium product candidate containing immuno-regulatory proteins and exosomes, produced under GMP-like conditions and third-party tested.
Processing of peripheral blood submissions to recover naturally occurring pluripotent stem cells for immediate therapeutic use or banking.
Cryopreservation and long-term storage services for recovered pluripotent cells and derived cell lines, with SOP-driven operations in FDA-licensed facilities.
In vitro generation of organoid tissue buds from peripheral blood-derived pluripotent cells for laboratory testing, drug discovery, and potential tissue-engineering applications.
Manufacture and formulation of a cell-free mesenchymal stem cell-conditioned medium product candidate containing immuno-regulatory proteins and exosomes, produced under GMP-like conditions and third-party tested.
Expertise Areas
- Peripheral blood-derived pluripotent stem cell isolation
- Cell banking and biobanking (cryopreservation)
- MSC-conditioned medium therapeutics
- 3D organoid development for drug discovery and tissue engineering
Key Technologies
- Peripheral blood-derived pluripotent stem cell isolation
- Immortalized mesenchymal stem cell lines
- Conditioned medium (cell-free) production
- Photo-activation / light stimulation of cells
News & Updates
A Simplified Approach: Isolation of Small Pluripotent Stem Cells Derived from Human Peripheral Blood
This article discusses the challenges and advancements in isolating very small embryonic-like stem cells for regenerative medicine.
Research on the effects of conditioned medium from human adipose-derived stem cells on inflammation and fibrosis in lung conditions.
A Simplified Approach: Isolation of Small Pluripotent Stem Cells Derived from Human Peripheral Blood
This article discusses the challenges and advancements in isolating very small embryonic-like stem cells for regenerative medicine.
Research on the effects of conditioned medium from human adipose-derived stem cells on inflammation and fibrosis in lung conditions.